Inhalation drug delivery technologies

Skyepharma has extensive know-how and experience in the application of inhalation formulationdevice and process technologies covering both Dry Powder Inhaler (DPI) and Metered Dose Inhaler (MDI) products.

Each drug, target product profile and device presents specific challenges in order to meet formulation, clinical, regulatory, manufacturing and patient-use requirements. We apply our many years of experience in the development of different products and devices to maximise the probability of project success. Where appropriate we apply our own proprietary formulation and device technologies to solve particular problems and to add additional patent protection to the product.

> Find out more about our inhalation formulation technologies
> Find out more about our inhalation device technologies

Inhalation device technologies

Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom

Contact addresses

Skyepharma PLC
46-48 Grosvenor Gardens
London
SW1W 0EB
UK

Tel: +44 207 881 0524

Fax: +44 207 881 1199

E-mail us

Skyepharma AG
Eptingerstrasse 61
4132 Muttenz
Switzerland

Tel: +41 61 467 5555

Fax: +41 61 467 5500

E-mail us

This website works best using cookies.